Persbericht: Programma bekend van gebruikersevent GiLab Commit 2019
Amsterdam — 30 augustus 2019 — GitLab, het DevOps platform,... Lees verder →
- Investigational oral MET inhibitor has previously received SAKIGAKE 'fast-track' regulatory designation in Japan - MET exon 14 skipping alterations and MET amplifications ...
Lees verderASCO Abstract # Tepotinib (MET kinase inhibitor): 9005 Not intended for UK- , Canada- or US-based media DARMSTADT, Germany, June 3, 2019 /PRNewswire/ -- -- ...
Lees verderDARMSTADT, Germany, May 15, 2019 /PRNewswire/ -- Not intended for UK- , Canada- or US-based media ASCO Abstract # Bintrafusp alfa (bifunctional fusion protein): TPS9114; ...
Lees verder- Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research - Helps modify difficult-to-access regions of the genome, ...
Lees verderDARMSTADT, Germany and NEW YORK, December 21, 2018 /PRNewswire/ -- Not intended for US, Canada and UK-based media Merck and Pfizer Inc. today announced that data from a ...
Lees verderDARMSTADT, Germany, December 20, 2018 /PRNewswire/ -- The information contained is not intended for distribution in the USA, Canada or the UK - European Medicine ...
Lees verderDARMSTADT, Germany and NEW YORK, November 19, 2018 /PRNewswire/ -- Not intended for US, Canada and UK-based media Merck and Pfizer Inc. today announced that the Phase III ...
Lees verderDARMSTADT, Germany, October 22, 2018 /PRNewswire/ -- The information contained is not intended for distribution in the USA, Canada or the UK ESMO Abstract # M7824 (TGF ...
Lees verder- Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research - Expands company's foundational CRISPR cutting and integration ...
Lees verderDARMSTADT, Germany, June 3, 2018 /PRNewswire/ -- ASCO Abstract # Tepotinib (c-Met kinase inhibitor): 9082, 9016; M7824 (TGF-ss trap/anti-PD-L1): 3007, 9017, 2566; M2698 (dual ...
Lees verder